Use of Hydroxyurea in Chronic Myeloid Leukemia During Pregnancy: a Case Report

Overview

Journal Am J Obstet Gynecol

Publisher Elsevier

Specialty Gynecology & Obstetrics

Date 1991 Sep 1

PMID 1892181

Citations 10

Authors

M Patel

I A Dukes

J C Hull

Affiliations

Soon will be listed here.

Abstract

The concomitant occurrence of pregnancy and chronic myeloid leukemia is uncommon. The use of hydroxyurea in chronic myeloid leukemia during pregnancy is unknown. We report on a patient with chronic myeloid leukemia in whom hydroxyurea was used during pregnancy with a successful outcome for both mother and fetus.

Citing Articles

Hematologic malignancies during pregnancy: A review.

Mahmoud H, Samra M, Fathy G J Adv Res. 2016; 7(4):589-96.

PMID: 27408762 PMC: 4921778. DOI: 10.1016/j.jare.2016.02.001.

An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians.

Granatowicz A, Piatek C, Moschiano E, El-Hemaidi I, Armitage J, Akhtari M Korean J Fam Med. 2015; 36(5):197-202.

PMID: 26435808 PMC: 4591383. DOI: 10.4082/kjfm.2015.36.5.197.

Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review.

Santorsola D, Abruzzese E Mediterr J Hematol Infect Dis. 2015; 7(1):e2015020.

PMID: 25745547 PMC: 4344172. DOI: 10.4084/MJHID.2015.020.

Tyrosine kinase inhibitors and pregnancy.

Abruzzese E, Trawinska M, Perrotti A, de Fabritiis P Mediterr J Hematol Infect Dis. 2014; 6(1):e2014028.

PMID: 24804001 PMC: 4010610. DOI: 10.4084/MJHID.2014.028.

Imatinib use in pregnancy.

Webb M, Jafta D Turk J Haematol. 2014; 29(4):405-8.

PMID: 24385730 PMC: 3781616. DOI: 10.5505/tjh.2012.82542.